²é¿´: 628  |  »Ø¸´: 0

yexuqing

ľ³æÖ®Íõ (ÎÄѧ̩¶·)

Ì«ÑôϵϵÖ÷ÈÎ

[½»Á÷] ±±¾©Í¬ÈÊÒ½ÔºÒ»ÂÛÎı»³·£ºÉæÖظ´·¢±í¡¢Î±Ôì×÷ÕßÉí·Ý¡¢±àÔìÊý¾Ý

ÒòÉæÏÓÖØ¸´·¢±í¡¢ αÔì×÷ÕßÉí·Ý¡¢±àÔìÊý¾ÝµÈÔ­Òò£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈΡ¢±±¾©ÊÐÌÇÄò²¡Ñо¿ËùËù³¤Ñî½ð¿üºÍÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈÎҽʦÖܽ¨²©ÊðÃûΪͨѶ×÷ÕßµÄһƪÑо¿ÂÛÎı»³·»Ø¡£

3ÔÂ10ÈÕ£¬¹ú¼ÊѧÊõÆÚ¿¯¡¶Ò½Ñ§¡·£¨Medicine£©·¢±íÒ»·Ý³·¸å˵Ã÷³Æ£¬¸ÃÆÚ¿¯µÚ96¾íµÚ15ÆÚÉÏ·¢±íµÄһƪÂÛÎÄ£¬ÒòÉæÏÓÖØ¸´·¢±í¡¢ αÔì×÷ÕßÉí·Ý¡¢±àÔìÊý¾ÝºÍαÔìÐèҪͨѶ×÷ÕßÐí¿ÉµÄ³ö°æÐ­Òé¶ø±»³·»Ø¡£

ÉæÊÂÂÛÎĵıêÌâÊÇ¡¶ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍ˺ÍT2DÊÜÊÔÕßÂýÐÔÉöÔ༲²¡µÄ·çÏÕ£º²¡Àý¶ÔÕպͼÁÁ¿·´Ó¦·ÖÎö¡·£¨Subclinical hypothyroidism and the risk of chronic kidney disease in T2D subjects: A case-control and dose-response  analysis£©¡£

¸ÃÂÛÎÄÓÚ2017Äê4Ô·¢±íÔÚѧÊõÆÚ¿¯¡¶Ò½Ñ§¡·£¨Medicine£©ÉÏ¡£ÆäͨѶ×÷Õß·Ö±ðÊÇÖܽ¨²©(Jian-Bo Zhou)ºÍÑî½ð¿ü(Jin-Kui Yang)¡£

ÆäÖУ¬Öܽ¨²©(Jian-Bo Zhou)µÄÊðÃûµ¥Î»ÊÇÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿Æ¡£Ñî½ð¿ü(Jin-Kui Yang)µÄÊðÃûµ¥Î»ÊÇÊ×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃڿƺÍÌÇÄò²¡Ñо¿·ÀÖα±¾©ÊÐÖØµãʵÑéÊÒ¡£


2023Äê3ÔÂ10Èյij·¸å˵Ã÷¡£

ÉæÊÂÂÛÎijƣ¬ËäÈ»´ËǰÓÐÖ¤¾Ý±íÃ÷ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍËÖ¢(SCH)ÓëÐÄѪ¹Ü¼²²¡³ÊÕýÏà¹Ø£¬µ«ÓëÂýÐÔÉöÔ༲²¡(CKD)Ö®¼äµÄ¹ØÏµÉв»Çå³þ¡£¸ÃÑо¿ÕÐļÁË3270Àý2ÐÍÌÇÄò²¡ºÏ²¢¼×¿º»¼ÕߺÍ545Àý2ÐÍÌÇÄò²¡ºÏ²¢¼×¿º»¼Õߣ¬²¢½øÐÐÜöÝÍ·ÖÎö¡£Ñо¿·¢ÏÖ£¬ÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍËÖ¢(SCH)¿ÉÄÜÊÇ2ÐÍÌÇÄò²¡ÊÜÊÔÕßÖÐÂýÐÔÉöÔ༲²¡µÄÒ»¸öÖØÒª·çÏÕÒòËØ¡£ÔÚ2ÐÍÌÇÄò²¡ÊÜÊÔÕßÖУ¬ÑªÇå´Ù¼××´ÏÙ¼¤ËØ(TSH)µÄÉý¸ßºÍÂýÐÔÉöÔ༲²¡Ö®¼äÏÔʾ³öÏßÐÔÇ÷ÊÆ¡£

µ«ÔÚ·¢±í½ü6Äêºó£¬ÉÏÊöÂÛÎı»³·»Ø¡£

¹«¿ª×ÊÁÏÏÔʾ£¬ÉæÊÂÂÛÎĵÄͨѶ×÷ÕßÖܽ¨²©ÓëÑî½ð¿üÔÚ±±¾©Í¬ÈÊÒ½Ôº±»ÁÐΪͬһ¼¼ÊõÍŶӡ£

Öܽ¨²©£¬ÏµÒ½Ñ§²©Ê¿£¬Ö÷ÈÎҽʦ£¬¸±½ÌÊÚ£¬Ë¶Ê¿Ñо¿Éúµ¼Ê¦£¬±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃڿƸ±Ö÷ÈÎÖ÷³Ö¹¤×÷£»2010Äê±ÏÒµÓÚÊ×¶¼Ò½¿Æ´óѧ£¬Í¬Äê8ÔÂÖÁ¸ÃÔºÄÚ·ÖÃڿƹ¤×÷ÖÁ½ñ¡£¶àÄê´ÓÊÂÄÚ·ÖÃÚ´úл²¡»ù´¡¼°ÁÙ´²¹¤×÷£¬ÖÂÁ¦ÓÚÀÏÄêÌÇÄò²¡¡¢¼××´ÏÙÏà¹ØÑÛ²¡¡¢ÄÑÖÎÐÔ¸ßѪѹµÈ¼²²¡ÕïÖΣ»ÆäÎÄÕ·¢±íÔÚMetabolism, Ageing Research Reviews, Neurosci Biobehav Rev, Diabetes Care£»µ£ÈÎJournal of Alzheimer¡¯s Disease¸±Ö÷±à¡¢Frontiers in Neuroscience¡¢Frontiers in EndocrinologyÌØÑû¸±Ö÷±à¡£

Ñî½ð¿ü£¬ÏµÖ÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦£»ÏÖÈα±¾©ÊÐÌÇÄò²¡Ñо¿ËùËù³¤£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½ÔºÄÚ·ÖÃÚ¿ÆÖ÷ÈΣ¬Ê×¶¼Ò½¿Æ´óѧÄÚ·ÖÃÚÓë´úл²¡Ñ§ÏµÖ÷ÈΣ»×÷ΪÊ×ϯ¿ÆÑ§¼Ò³Ðµ£¹ú¼ÒÖØµãÑз¢ÏîÄ¿1ÏÖ÷³Ö¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØµã¡¢¹ú¼ÊºÏ×÷¼°ÃæÉÏÏîÄ¿¹²7Ïî¡£·¢±íÂÛÎÄ269ƪ£¬±»Òý2505´Î¡£´ú±íÐÔÂÛÎÄ·¢±íÔÚ¡¶Diabetes Care¡· (IF£º15.3)¹²4ƪ£¬¡¶Cell Reports¡·1ƪ£¬¡¶Nature Communications¡·1ƪ£¬¡¶Diabetes¡·2ƪ¡£ÆäÖнü10ÄêÒÔµÚÒ»/ͨѶ×÷Õß·¢±íSCIÂÛÖø54ƪ£»×÷ΪµÚÒ»Íê³ÉÈË»ñÊ¡¼¶¿Æ¼¼½±6Ï¹ú¼ÒÐÂÒ©Ö¤Êé2Ïî¡£

ÖµµÃ×¢ÒâµÄÊÇ£¬ÁíÓÐһƪÆäËû×÷ÕßÊðÃûµÄÂÛÎÄËäÈ»±»ÁÐÔÚ³·¸åÉùÃ÷ÖÐ×÷Ϊ±»³·¸åÂÛÎÄÉæÏÓ¡°Öظ´·¢±í¡±µÄÂÛÎÄ£¬µ«ÆäÁÐÃ÷µÄ¾íºÅºÍÒ³Âë¼°±êÌâ¾ùδÄܼìË÷µ½¡£¸ÃÂÛÎĵıêÌâÊÇ¡¶T2DM»¼ÕßÂýÐÔÉöÔ༲²¡ÓëÑÇÁÙ´²¼××´ÏÙ¹¦ÄܼõÍ˵ĹØÏµ£º²¡Àý¶ÔÕպͼÁÁ¿·´Ó¦·ÖÎö¡·£¨Relationship between chronic kidney disease and subclinical hypothyroidism in T2DM subjects: a case-control and dose-response analysis£©¡£

13ÈÕ£¬Ê×¶¼Ò½¿Æ´óѧ¸½Êô±±¾©Í¬ÈÊÒ½Ôº¿Æ¼¼´¦¹¤×÷ÈËÔ±ÏòÅìÅȿƼ¼±íʾ£¬¶ÔÉÏÊö³·¸åÇé¿ö²»ÖªÇé¡£

ÔðÈα༭£ºÎâԾΰ
ͼƬ±à¼­£º½¯Á¢¶¬
»Ø¸´´ËÂ¥
----
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ yexuqing µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 276Çóµ÷¼Á ±¾¿ÆÌì½ò¹¤Òµ´óѧ Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ0855 +4 ·lyh123 2026-03-06 6/300 2026-03-07 11:37 by shdliugang
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤ 298 µ÷¼Á +11 СÎ÷ЦÎûÎû 2026-03-03 11/550 2026-03-07 10:30 by Ò»Ö±×ß²»ÒªÍ£
[¿¼ÑÐ] 334Çóµ÷¼Á +6 Trying] 2026-03-06 6/300 2026-03-07 09:11 by Mornach1988
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤£¬Ò»Ö¾Ô¸¹ãÖÝ985£¬Çóµ÷¼Á +10 qqyyaill 2026-03-05 10/500 2026-03-06 15:58 by ´ÏÃ÷µÄ´óËÉÊó
[¿¼ÑÐ] ¸ß·Ö×Ó»¯Ñ§ÓëÎïÀíµ÷¼Á +6 ºÃºÃºÃ1233 2026-02-28 17/850 2026-03-06 15:42 by ºÃºÃºÃ1233
[¿¼ÑÐ] 289Çóµ÷¼Á +3 ³Û¹â¾ø¾° 2026-03-04 4/200 2026-03-06 12:34 by ³Û¹â¾ø¾°
[¿¼ÑÐ] Çóµ÷¼Á£¬Ñ§Ð£Ñо¿Ëù¶¼¿ÉÒÔ£¬²ÄÁÏÓ뻯¹¤267·Ö +6 wmx1 2026-03-05 6/300 2026-03-05 20:01 by houyaoxu
[¿¼ÑÐ] ûÉϰ¶µÄ¿´¹ýÀ´ +3 tangxiaotian 2026-03-01 5/250 2026-03-05 13:56 by tangxiaotian
[¿¼ÑÐ] 085701»·¾³¹¤³Ì Çóµ÷¼Á +7 xiiiia 2026-03-04 7/350 2026-03-05 09:49 by ÈÈÇéɳĮ
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£ÖÝ´óѧ£¬Ñ§Ë¶£¬ÎïÀí»¯Ñ§£¬ 333Çóµ÷¼Á +5 Àîħٶ·Åñ 2026-03-04 5/250 2026-03-04 18:33 by houyaoxu
[¿¼ÑÐ] Äܶ¯297Çóµ÷¼Á£¬±¾¿Æ´¨´ó +4 ÉÛ11 2026-03-04 4/200 2026-03-04 15:29 by lylylyheart
[¿¼ÑÐ] ²ÄÁÏ325Çóµ÷¼Á 30+5 mariusuki 2026-03-02 10/500 2026-03-04 09:24 by njzyff
[¿¼ÑÐ] 0854×Ü·Ö272 +5 ´òС¾ÍÊÇÀÏʵÈË 2026-03-02 6/300 2026-03-04 01:41 by ouhaiyu
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 ½ÜÄá¹êaaa 2026-03-03 4/200 2026-03-03 23:06 by zhukairuo
[¿¼ÑÐ] 267Çóµ÷¼Á +6 µöÓãÀÐas 2026-03-02 6/300 2026-03-03 13:59 by 13589
[¿¼ÑÐ] »¯¹¤270Çóµ÷¼Á +10 ʲôÃû×Öqwq 2026-03-02 10/500 2026-03-03 13:54 by NUAAZXWS
[¿¼ÑÐ] 261Çóµ÷¼Á +3 ½lh 2026-03-01 3/150 2026-03-02 19:32 by zhukairuo
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ²ÄÁÏÓ뻯¹¤325Çóµ÷¼Á +5 °ë½ØµÄÊ«0927 2026-03-02 5/250 2026-03-02 18:37 by Ã÷ÁÁ9527
[¿¼ÑÐ] 291 Çóµ÷¼Á +3 »¯¹¤2026½ì±ÏÒµÉ 2026-03-02 3/150 2026-03-02 12:55 by houyaoxu
[¿¼ÑÐ] 328Çóµ÷¼Á +3 aaadim 2026-03-01 5/250 2026-03-01 17:29 by njzyff
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û